Clinical Trial Update: A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating mavorixafor in participants with congenital and acquired primary autoimmune and idiopathic chronic neutropenic disorders who h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neutropenia

Drugs mentioned

• Mavorixafor (mavorixafor)

Snippet

Sponsor: X4 Pharmaceuticals | Conditions: Neutropenia | Phase 3 | Status: RECRUITING